IHS Chemical Week
FINE CHEMICALS/BIOTECH

Merck KGaA steps up investment in biosimilar activities

6:36 AM MDT | September 21, 2014 | Natasha Alperowicz

Merck KGaA, says its biopharmaceutical division is well on track with the implementation of the group’s “Fit for 2018” transformation and growth program. At an analysts and investor day at Darmstadt on Friday of its Merck Serono biopharma...


Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com
MORE FINE CHEMICALS/BIOTECH

Bayer CropScience forecasts significant growth in agchems markets, confirms capex plans

Bayer CropScience (BCS), the world’s second largest agricultural chemicals producer, at its annual press briefing in Monheim, Germany today said that it is optimistic about future development of the agchems markets and it will continue to invest...

Lupin to manufacture Merck Serono drugs under $1.5-billion deal?

Merck KGaA today declined to comment on a report in The Economic Times of India that it is close to signing a deal, worth $1.5 billion, with India’s pharma major Lupin (Mumbai). The report, citing sources close to the deal, says Lupin is in advanced...

Merck Serono confirms pharma alliance with Lupin targeting emerging markets

Merck Serono, the biopharmaceutical division of Merck KGaA, today confirmed that it is establishing a long-term strategic partnership with Lupin (Mumbai). Lupin will support Merck Serono implement the company’s initiative to expand its general medicines...

Pharma/fine chemicals roundup—16 September 2014

Seattle Genetics and Genmab enter into antibody-drug conjugate collaboration Biotechnology companies Seattle Genetics (Bothell, WA) and Genmab (Copenhagen) say that they have entered into an additional antibody-drug conjugate (ADC) collaboration. Genmab...

Cargill sues Syngenta over sales of GMO corn, Syngenta says lawsuit without merit (update)

Cargill said on Friday that it had filed a lawsuit against Syngenta Seeds in Louisiana state court, seeking damages from Syngenta for commercializing its Agrisure Viptera (MIR 162) corn seed before the product obtained import approval from China...

Eastman to acquire Taminco for $2.8 billion

Eastman Chemical announced today that it plans to acquire Taminco for $2.8 billion, or $26/share, including $1 billion of assumed debt. Taminco, a major producer of alklylamines and alkylamine derivatives, was taken public by private equity firm Apollo...

Pharma/fine chemicals roundup—9 September 2014

Mercachem to acquire Synthon’s API operations at Prague Mercachem (Nijmegen, Netherlands) says that it has agreed to acquire pharmaceutical company Synthon’s (Nijmegen) Prague-based laboratory and pilot scale operations for the manufacturing of...

Mercachem to acquire Synthon’s API operations at Prague

Mercachem (Nijmegen, Netherlands) says that it has agreed to acquire pharmaceutical company Synthon’s (Nijmegen) Prague-based laboratory and pilot scale operations for the manufacturing of active pharmaceutical ingredients (API). Financial details of...

Bayer CropScience outlines targets, bets on biologics

Bayer CropScience (BCS) has today given insight into its targets and projects it is currently working on. In exclusive interviews with CW on the sidelines of today’s inauguration of a new facility at West Sacramento, CA, Liam Condon, CEO, Jim Blome...

Fine Chemicals/Biotech Archives »











 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa